Wade H. Aaron

652 total citations
18 papers, 404 citations indexed

About

Wade H. Aaron is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wade H. Aaron has authored 18 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wade H. Aaron's work include CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Wade H. Aaron is often cited by papers focused on CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Wade H. Aaron collaborates with scholars based in United States, United Kingdom and Germany. Wade H. Aaron's co-authors include Thomas Toneff, Vivian Hook, Sukkid Yasothornsrikul, Richard J. Austin, Timothy Hoey, Derek E. Piper, Charles S. Craik, Ami S. Bhatt, Sylvia Herter and Ping Cao and has published in prestigious journals such as Blood, Biochemistry and Cancer Research.

In The Last Decade

Wade H. Aaron

17 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wade H. Aaron United States 8 178 109 70 60 55 18 404
Katarina Jansson Sweden 14 217 1.2× 56 0.5× 59 0.8× 44 0.7× 23 0.4× 19 547
Luciana M. Laguinge United States 7 309 1.7× 122 1.1× 36 0.5× 40 0.7× 20 0.4× 9 471
N Li China 6 328 1.8× 102 0.9× 40 0.6× 92 1.5× 20 0.4× 13 466
Andreas R. Baudy United States 10 343 1.9× 90 0.8× 46 0.7× 21 0.3× 38 0.7× 12 528
Jeong Yong Jeon South Korea 15 316 1.8× 116 1.1× 20 0.3× 49 0.8× 41 0.7× 20 559
Friederike C. von Lintig United States 11 451 2.5× 198 1.8× 59 0.8× 60 1.0× 24 0.4× 13 636
Vasudha Sehgal United States 7 307 1.7× 117 1.1× 31 0.4× 27 0.5× 37 0.7× 11 503
Michela Cortesi Italy 15 291 1.6× 192 1.8× 45 0.6× 38 0.6× 10 0.2× 25 651
Igor Spivak Germany 9 240 1.3× 34 0.3× 33 0.5× 33 0.6× 22 0.4× 14 443
Yun Gyu Park South Korea 17 523 2.9× 201 1.8× 26 0.4× 46 0.8× 23 0.4× 23 736

Countries citing papers authored by Wade H. Aaron

Since Specialization
Citations

This map shows the geographic impact of Wade H. Aaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wade H. Aaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wade H. Aaron more than expected).

Fields of papers citing papers by Wade H. Aaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wade H. Aaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wade H. Aaron. The network helps show where Wade H. Aaron may publish in the future.

Co-authorship network of co-authors of Wade H. Aaron

This figure shows the co-authorship network connecting the top 25 collaborators of Wade H. Aaron. A scholar is included among the top collaborators of Wade H. Aaron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wade H. Aaron. Wade H. Aaron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Austin, Richard J., Wade H. Aaron, Golzar Hemmati, et al.. (2021). Abstract 913: FLT3-targeting TriTACs are T cell engagers for treatment of acute myeloid leukemia. Cancer Research. 81(13_Supplement). 913–913. 1 indexed citations
4.
5.
Austin, Richard J., Bryan D. Lemon, Wade H. Aaron, et al.. (2020). Preclinical Characterization of HPN536, a Trispecific, T-Cell–Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors. Clinical Cancer Research. 27(5). 1452–1462. 35 indexed citations
6.
Aaron, Wade H., Richard J. Austin, Golzar Hemmati, et al.. (2019). Abstract C033: HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer. Molecular Cancer Therapeutics. 18(12_Supplement). C033–C033. 11 indexed citations
7.
Lemon, Bryan D., Wade H. Aaron, Richard J. Austin, et al.. (2018). Abstract 1773: HPN424, a half-life extended, PSMA/CD3-specific TriTAC for the treatment of metastatic prostate cancer. Cancer Research. 78(13_Supplement). 1773–1773. 6 indexed citations
8.
Austin, Richard J., Wade H. Aaron, Patrick A. Baeuerle, et al.. (2018). Abstract 1781: HPN536, a T cell-engaging, mesothelin/CD3-specific TriTAC for the treatment of solid tumors. Cancer Research. 78(13_Supplement). 1781–1781. 7 indexed citations
9.
Wesche, Holger, Wade H. Aaron, Richard J. Austin, et al.. (2018). Abstract 3814: TriTACs are novel T cell-engaging therapeutic proteins optimized for the treatment of solid tumors and for long serum half-life. Cancer Research. 78(13_Supplement). 3814–3814. 5 indexed citations
10.
Law, Che‐Leung, Wade H. Aaron, Golzar Hemmati, et al.. (2018). Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma. Blood. 132(Supplement 1). 3225–3225. 12 indexed citations
11.
Kaizerman, Jacob A., Wade H. Aaron, Songzhu An, et al.. (2010). Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines. Bioorganic & Medicinal Chemistry Letters. 20(15). 4607–4610. 20 indexed citations
12.
Herter, Sylvia, Derek E. Piper, Wade H. Aaron, et al.. (2005). Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochemical Journal. 390(1). 125–136. 152 indexed citations
13.
Sei, Catherine A., Thomas Toneff, Wade H. Aaron, & Vivian Hook. (2003). Regulation of ACTH levels in anterior pituitary cells during stimulated secretion: evidence for aspartyl and cysteine proteases in the cellular metabolism of ACTH. Peptides. 24(5). 717–725. 7 indexed citations
14.
Aaron, Wade H., et al.. (2003). Obliteration of α‐melanocyte‐stimulating hormone derived from POMC in pituitary and brains of PC2‐deficient mice. Journal of Neurochemistry. 86(3). 556–563. 49 indexed citations
15.
16.
17.
Yasothornsrikul, Sukkid, Wade H. Aaron, Thomas Toneff, & Vivian Hook. (1999). Evidence for the Proenkephalin Processing Enzyme Prohormone Thiol Protease (PTP) as a Multicatalytic Cysteine Protease Complex:  Activation by Glutathione Localized to Secretory Vesicles. Biochemistry. 38(23). 7421–7430. 37 indexed citations
18.
Aaron, Wade H., et al.. (1978). [Slightly myelodepressive drugs in the treatment of acute lymphoblastic leukemia in the adult].. PubMed. 114(1). 37–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarina Jansson Breakdown of academic impact, for papers by Luciana M. Laguinge Breakdown of academic impact, for papers by N Li Breakdown of academic impact, for papers by Andreas R. Baudy Breakdown of academic impact, for papers by Jeong Yong Jeon Breakdown of academic impact, for papers by Friederike C. von Lintig Breakdown of academic impact, for papers by Vasudha Sehgal Breakdown of academic impact, for papers by Michela Cortesi Breakdown of academic impact, for papers by Igor Spivak Breakdown of academic impact, for papers by Yun Gyu Park
Rankless by CCL
2026